Morphotek, a wholly-owned subsidiary of Eisai, has opened a new pilot manufacturing plant in Exton, Pennsylvania, US, for the production of biological-based therapeutics to help accelerate early-stage clinical trials.
Morphotek opens new manufacturing plant in us